Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Eradication of a multi-drug resistant, carbapenemase-producing Klebsiella pneumoniae isolate following oral and intra-rectal therapy with a custom-made, lytic bacteriophage preparation.

Corbellino M, Kieffer N, Kutateladze M, Balarjishvili N, Leshkasheli L, Askilashvili L, Tsertsvadze G, Rimoldi SG, Nizharadze D, Hoyle N, Nadareishvili L, Antinori S, Pagani C, Scorza DG, Romanò ALL, Ardizzone S, Danelli P, Gismondo MR, Galli M, Nordmann P, Poirel L.

Clin Infect Dis. 2019 Aug 15. pii: ciz782. doi: 10.1093/cid/ciz782. [Epub ahead of print]

PMID:
31414123
2.

Insulin/IGF-1 Drives PERIOD Synthesis to Entrain Circadian Rhythms with Feeding Time.

Crosby P, Hamnett R, Putker M, Hoyle NP, Reed M, Karam CJ, Maywood ES, Stangherlin A, Chesham JE, Hayter EA, Rosenbrier-Ribeiro L, Newham P, Clevers H, Bechtold DA, O'Neill JS.

Cell. 2019 May 2;177(4):896-909.e20. doi: 10.1016/j.cell.2019.02.017. Epub 2019 Apr 25.

3.

Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability.

Szulc P, Naylor K, Pickering ME, Hoyle N, Eastell R, Leary E.

Ann Biol Clin (Paris). 2018 Aug 1;76(4):373-391. doi: 10.1684/abc.2018.1363. Review.

PMID:
30078776
4.

Phage therapy against Achromobacter xylosoxidans lung infection in a patient with cystic fibrosis: a case report.

Hoyle N, Zhvaniya P, Balarjishvili N, Bolkvadze D, Nadareishvili L, Nizharadze D, Wittmann J, Rohde C, Kutateladze M.

Res Microbiol. 2018 Nov;169(9):540-542. doi: 10.1016/j.resmic.2018.05.001. Epub 2018 May 16.

PMID:
29777836
5.

A role for bone turnover markers β-CrossLaps (CTX) and amino-terminal propeptide of type I collagen (PINP) as potential indicators for disease progression from MGUS to multiple myeloma.

Vallet S, Hoyle NR, Kyle RA, Podar K, Pecherstorfer M.

Leuk Lymphoma. 2018 Oct;59(10):2431-2438. doi: 10.1080/10428194.2017.1421757. Epub 2018 Jan 18.

PMID:
29345175
7.

Circadian actin dynamics drive rhythmic fibroblast mobilization during wound healing.

Hoyle NP, Seinkmane E, Putker M, Feeney KA, Krogager TP, Chesham JE, Bray LK, Thomas JM, Dunn K, Blaikley J, O'Neill JS.

Sci Transl Med. 2017 Nov 8;9(415). pii: eaal2774. doi: 10.1126/scitranslmed.aal2774.

8.

Phage Therapy in a 16-Year-Old Boy with Netherton Syndrome.

Zhvania P, Hoyle NS, Nadareishvili L, Nizharadze D, Kutateladze M.

Front Med (Lausanne). 2017 Jul 3;4:94. doi: 10.3389/fmed.2017.00094. eCollection 2017.

9.

Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability.

Szulc P, Naylor K, Hoyle NR, Eastell R, Leary ET; National Bone Health Alliance Bone Turnover Marker Project.

Osteoporos Int. 2017 Sep;28(9):2541-2556. doi: 10.1007/s00198-017-4082-4. Epub 2017 Jun 19. Review.

PMID:
28631236
10.

Mammalian Circadian Period, But Not Phase and Amplitude, Is Robust Against Redox and Metabolic Perturbations.

Putker M, Crosby P, Feeney KA, Hoyle NP, Costa ASH, Gaude E, Frezza C, O'Neill JS.

Antioxid Redox Signal. 2018 Mar 1;28(7):507-520. doi: 10.1089/ars.2016.6911. Epub 2017 Jun 26.

11.

Daily magnesium fluxes regulate cellular timekeeping and energy balance.

Feeney KA, Hansen LL, Putker M, Olivares-Yañez C, Day J, Eades LJ, Larrondo LF, Hoyle NP, O'Neill JS, van Ooijen G.

Nature. 2016 Apr 21;532(7599):375-9. doi: 10.1038/nature17407. Epub 2016 Apr 13.

12.

Oxidation-reduction cycles of peroxiredoxin proteins and nontranscriptional aspects of timekeeping.

Hoyle NP, O'Neill JS.

Biochemistry. 2015 Jan 20;54(2):184-93. doi: 10.1021/bi5008386. Epub 2014 Dec 30. Review.

13.

Granules harboring translationally active mRNAs provide a platform for P-body formation following stress.

Lui J, Castelli LM, Pizzinga M, Simpson CE, Hoyle NP, Bailey KL, Campbell SG, Ashe MP.

Cell Rep. 2014 Nov 6;9(3):944-54. doi: 10.1016/j.celrep.2014.09.040. Epub 2014 Oct 23.

14.

Personalized medicine approaches for colon cancer driven by genomics and systems biology: OncoTrack.

Henderson D, Ogilvie LA, Hoyle N, Keilholz U, Lange B, Lehrach H; OncoTrack Consortium.

Biotechnol J. 2014 Sep;9(9):1104-14. doi: 10.1002/biot.201400109. Epub 2014 Jul 29. Review.

15.

Circadian clocks, brain function, and development.

Frank E, Sidor MM, Gamble KL, Cirelli C, Sharkey KM, Hoyle N, Tikotzky L, Talbot LS, McCarthy MJ, Hasler BP.

Ann N Y Acad Sci. 2013 Dec;1306:43-67. doi: 10.1111/nyas.12335. Review.

PMID:
24329517
16.

Circadian rhythms: hijacking the cyanobacterial clock.

Hoyle NP, O'Neill JS.

Curr Biol. 2013 Dec 2;23(23):R1050-2. doi: 10.1016/j.cub.2013.09.046.

17.

Transcript processing and export kinetics are rate-limiting steps in expressing vertebrate segmentation clock genes.

Hoyle NP, Ish-Horowicz D.

Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):E4316-24. doi: 10.1073/pnas.1308811110. Epub 2013 Oct 22.

18.

PKA isoforms coordinate mRNA fate during nutrient starvation.

Tudisca V, Simpson C, Castelli L, Lui J, Hoyle N, Moreno S, Ashe M, Portela P.

J Cell Sci. 2012 Nov 1;125(Pt 21):5221-32. doi: 10.1242/jcs.111534. Epub 2012 Aug 16.

19.

[What happens when the child gets bacteriophage per os?].

Pagava KI, Gachechiladze KK, Korinteli IA, Dzuliashvili MG, Alavidze ZI, Hoyle N, Metskhvarishvili GD.

Georgian Med News. 2011 Jul-Aug;(196-197):101-5. Russian.

PMID:
21873760
20.

Glucose depletion inhibits translation initiation via eIF4A loss and subsequent 48S preinitiation complex accumulation, while the pentose phosphate pathway is coordinately up-regulated.

Castelli LM, Lui J, Campbell SG, Rowe W, Zeef LA, Holmes LE, Hoyle NP, Bone J, Selley JN, Sims PF, Ashe MP.

Mol Biol Cell. 2011 Sep;22(18):3379-93. doi: 10.1091/mbc.E11-02-0153. Epub 2011 Jul 27.

21.

Role of serum P1NP measurement for monitoring treatment response in osteoporosis.

Samoszuk M, Leuther M, Hoyle N.

Biomark Med. 2008 Oct;2(5):495-508. doi: 10.2217/17520363.2.5.495.

PMID:
20477426
22.

Subcellular localization of mRNA and factors involved in translation initiation.

Hoyle NP, Ashe MP.

Biochem Soc Trans. 2008 Aug;36(Pt 4):648-52. doi: 10.1042/BST0360648. Review.

PMID:
18631134
23.
24.

Stress-dependent relocalization of translationally primed mRNPs to cytoplasmic granules that are kinetically and spatially distinct from P-bodies.

Hoyle NP, Castelli LM, Campbell SG, Holmes LE, Ashe MP.

J Cell Biol. 2007 Oct 8;179(1):65-74. Epub 2007 Oct 1.

25.

Study of therapeutic potential of the experimental pseudomonas bacteriophage preparation.

Dzuliashvili M, Gabitashvili K, Golidjashvili A, Hoyle N, Gachechiladze K.

Georgian Med News. 2007 Jun;(147):81-8. Review.

PMID:
17660609
26.
27.

Serum and plasma fragments of C-telopeptides of type I collagen (CTX) are stable during storage at low temperatures for 3 years.

Qvist P, Munk M, Hoyle N, Christiansen C.

Clin Chim Acta. 2004 Dec;350(1-2):167-73.

PMID:
15530474
28.

Biochemical bone turnover markers are useful tools to assess changes in bone metabolism in marmosets.

Angeliewa A, Budde M, Schlachter M, Hoyle NR, Bauss F.

J Bone Miner Metab. 2004;22(3):192-7.

PMID:
15108060
29.

Evaluation of plasma carboxy-terminal cross-linking telopeptide of type I collagen concentration in horses.

Carstanjen B, Hoyle NR, Gabriel A, Hars O, Sandersen C, Amory H, Remy B.

Am J Vet Res. 2004 Jan;65(1):104-9.

PMID:
14719711
30.

Dose dependent effects on bone resorption and formation of intermittently administered intravenous ibandronate.

Christiansen C, Tankó LB, Warming L, Moelgaard A, Christgau S, Qvist P, Baumann M, Wieczorek L, Hoyle N.

Osteoporos Int. 2003 Jul;14(7):609-13. Epub 2003 Jun 26.

PMID:
12830369
31.

Oral ibandronate: changes in markers of bone turnover during adequately dosed continuous and weekly therapy and during different suboptimally dosed treatment regimens.

Tankó LB, Mouritzen U, Lehmann HJ, Warming L, Moelgaard A, Christgau S, Qvist P, Baumann M, Wieczorek L, Hoyle N, Christiansen C.

Bone. 2003 Jun;32(6):687-93.

PMID:
12810176
32.

Effect of feeding on bone turnover markers and its impact on biological variability of measurements.

Clowes JA, Hannon RA, Yap TS, Hoyle NR, Blumsohn A, Eastell R.

Bone. 2002 Jun;30(6):886-90.

PMID:
12052458
33.

Myelin basic protein concentrations in the CSF of children receiving methotrexate.

Pinkerton CR, Chessells JM, Hoyle NR.

J Clin Oncol. 1986 Jan;4(1):112-3. No abstract available.

PMID:
2416887
34.

Cerebrospinal fluid myelin basic protein immunoreactivity as an indicator of brain damage in children.

Levin SD, Hoyle NR, Brown JK, Thomas DG.

Dev Med Child Neurol. 1985 Dec;27(6):807-13.

PMID:
2419189
35.

Neuropeptides in neurological tumours.

Allen JM, Hoyle NR, Yeats JC, Ghatei MA, Thomas DG, Bloom SR.

J Neurooncol. 1985;3(3):197-202.

PMID:
2414412
36.

Pre- and postoperative changes in serum myelin basic protein immunoreactivity in neurosurgical patients.

Hoyle NR, Seeldrayers PA, Moussa AH, Paul EA, Thomas DG.

J Neurosurg. 1984 Jul;61(1):49-52.

PMID:
6202857
37.

Effect of electroconvulsive therapy on serum myelin basic protein immunoreactivity.

Hoyle NR, Pratt RT, Thomas DG.

Br Med J (Clin Res Ed). 1984 Apr 14;288(6424):1110-1.

38.

Myelin basic protein immunoreactivity in serum of neurosurgical patients.

Thomas DG, Hoyle NR, Seeldrayers P.

J Neurol Neurosurg Psychiatry. 1984 Feb;47(2):173-5.

39.

Pre- and post-operative changes in serum immunoglobulin level in neurosurgical patients.

Seeldrayers PA, Hoyle NR, Thomas DG.

Acta Neurochir (Wien). 1984;70(3-4):269-74.

PMID:
6711368
40.

Serum MBP immunoreactivity and immunoglobulin level as markers of tumour type.

Seeldrayers PA, Hoyle NR, Thomas DG.

J Neurooncol. 1984;2(2):141-5.

PMID:
6207275
42.

Self and non-self in the brain.

Darling JL, Hoyle NR, Thomas DG.

Immunol Today. 1981 Sep;2(9):176-81. doi: 10.1016/0167-5699(81)90059-1. No abstract available.

PMID:
25290073
43.

Outline structure of cytochrome c3 and consideration of its properties.

Dobson CM, Hoyle NJ, Geraldes CF, Bruschi M, LeGall J, Wright PE, Williams RJ.

Nature. 1974 May 31;249(456):425-9. No abstract available.

PMID:
4365942
44.

Electron exchange in pyridine solutions of iron(3) protoporphyrin IX chloride.

Weightman JA, Hoyle NJ, Williams RJ.

Biochim Biophys Acta. 1971 Sep 21;244(3):567-72. No abstract available.

PMID:
5160420

Supplemental Content

Support Center